How a Best-Practice Strategy for Sourcing Ancillary Materials Reduced Risk, Spending and Workload in a Global Diabetes Trial

How a Best-Practice Strategy for Sourcing Ancillary Materials Reduced Risk, Spending and Workload in a Global Diabetes Trial It’s impossible to run a global clinical trial of an investigational diabetes drug without ancillary materials. And as one leading multi-national pharmaceutical company recently learned, managing ancillaries can be a challenge every bit as complex as the trial itself.

Download this case study to learn how a sound strategy and solid execution plan enabled this company to overcome the challenges they faced to ensure that their patients received the ancillary products they needed.

Resource Library

Related Sites

Additional Resources